Literature DB >> 10749413

Lactobacilli and acidosis in children with short small bowel.

G Bongaerts1, J Bakkeren, R Severijnen, W Sperl, H Willems, T Naber, R Wevers, A van Meurs, J Tolboom.   

Abstract

BACKGROUND: In patients with a short small bowel, D-lactic acidemia and D-lactic aciduria are caused by intestinal lactobacilli. The purpose of this study was to obtain a detailed picture of the metabolic acidosis in young children with short small bowel.
METHODS: Feces, blood, and urine of children with short small bowel and acidosis were studied microbiologically and/or biochemically.
RESULTS: Previous findings were confirmed that more than 60% of the fecal flora of patients with small short bowel, who are not receiving antibiotics, consists of lactic acid-producing lactobacilli. In blood, D-lactic acid was the most prominent metabolite: the highest serum D-lactate (15.5 mmol/l) was observed in a sample taken immediately after the onset of hyperventilation. The highest D-lactate excretion was in urine collected some hours after the onset of hyperventilation, and amounted to 59 mol/mol creatinine. Acidosis in the patients with short small bowel was related to strongly increased serum D-lactate and anion gap and to strongly decreased serum bicarbonate and pH.
CONCLUSION: In children with small short bowel and acidosis, the common intestinal flora of mainly lactobacilli abundantly produces D-lactic acid from easily fermentable carbohydrates. Thus, these bacteria directly cause shifts of bicarbonate, pH, and base excess and indirectly cause shifts of the anion gap, as well as hyperventilation. These kinetic parameters are strongly associated.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10749413     DOI: 10.1097/00005176-200003000-00014

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  11 in total

1.  Evolutionary history of D-lactate dehydrogenases: a phylogenomic perspective on functional diversity in the FAD binding oxidoreductase/transferase type 4 family.

Authors:  Melania E Cristescu; Emmanuel E Egbosimba
Journal:  J Mol Evol       Date:  2009-09       Impact factor: 2.395

2.  Safety assessment of Bifidobacterium longum JDM301 based on complete genome sequences.

Authors:  Yan-Xia Wei; Zhuo-Yang Zhang; Chang Liu; Pradeep K Malakar; Xiao-Kui Guo
Journal:  World J Gastroenterol       Date:  2012-02-07       Impact factor: 5.742

Review 3.  Safety assessment of probiotics for human use.

Authors:  Mary Ellen Sanders; Louis M A Akkermans; Dirk Haller; Cathy Hammerman; James Heimbach; Gabriele Hörmannsperger; Geert Huys; Dan D Levy; Femke Lutgendorff; David Mack; Phoukham Phothirath; Gloria Solano-Aguilar; Elaine Vaughan
Journal:  Gut Microbes       Date:  2010-03-04

Review 4.  Potential Application of Living Microorganisms in the Detoxification of Heavy Metals.

Authors:  Runqiu Chen; Huaijun Tu; Tingtao Chen
Journal:  Foods       Date:  2022-06-27

5.  A reassessment of the PROPATRIA study and its implications for probiotic therapy.

Authors:  Ger P A Bongaerts; René S V M Severijnen
Journal:  Nat Biotechnol       Date:  2016-01       Impact factor: 54.908

Review 6.  D-lactic acidosis: an underrecognized complication of short bowel syndrome.

Authors:  N Gurukripa Kowlgi; Lovely Chhabra
Journal:  Gastroenterol Res Pract       Date:  2015-04-22       Impact factor: 2.260

7.  Vaginal biogenic amines: biomarkers of bacterial vaginosis or precursors to vaginal dysbiosis?

Authors:  Tiffanie M Nelson; Joanna-Lynn C Borgogna; Rebecca M Brotman; Jacques Ravel; Seth T Walk; Carl J Yeoman
Journal:  Front Physiol       Date:  2015-09-29       Impact factor: 4.566

Review 8.  Examining clinical similarities between myalgic encephalomyelitis/chronic fatigue syndrome and D-lactic acidosis: a systematic review.

Authors:  Amy Wallis; Michelle Ball; Sandra McKechnie; Henry Butt; Donald P Lewis; Dorothy Bruck
Journal:  J Transl Med       Date:  2017-06-07       Impact factor: 5.531

9.  Faecal D/L lactate ratio is a metabolic signature of microbiota imbalance in patients with short bowel syndrome.

Authors:  Camille Mayeur; Jean-Jacques Gratadoux; Chantal Bridonneau; Fatima Chegdani; Béatrice Larroque; Nathalie Kapel; Olivier Corcos; Muriel Thomas; Francisca Joly
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

10.  A Randomized Double Blind Controlled Safety Trial Evaluating d-Lactic Acid Production in Healthy Infants Fed a Lactobacillus reuteri-containing Formula.

Authors:  Konstantinos Papagaroufalis; Aikaterini Fotiou; Delphine Egli; Liên-Anh Tran; Philippe Steenhout
Journal:  Nutr Metab Insights       Date:  2014-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.